Nat Rev Endocrinol. 2010 Apr;6(4):186-8. doi: 10.1038/nrendo.2009.278.
A systematic review and meta-analysis by Dekkers et al. has assessed the effects of dopamine agonist withdrawal in patients with hyperprolactinemia. But not all dopamine agonists are the same, and much depends on the criteria for patient selection and the drug withdrawal strategy.
德克尔斯等人进行了一项系统评价和荟萃分析,评估了高泌乳素血症患者停用多巴胺激动剂的效果。但并非所有的多巴胺激动剂都一样,这在很大程度上取决于患者选择的标准和药物停药策略。